triamcinolone has been researched along with cytarabine in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (37.50) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (12.50) | 29.6817 |
2010's | 3 (37.50) | 24.3611 |
2020's | 1 (12.50) | 2.80 |
Authors | Studies |
---|---|
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Baron, M; Wechsler, HL | 1 |
Zuehlke, RL | 1 |
Nuss, DD | 1 |
Foutouhi, S; Kiuru, M; Simmons, E; Tartar, DM | 1 |
1 trial(s) available for triamcinolone and cytarabine
Article | Year |
---|---|
Herpes zoster--the best approach.
Topics: Adult; Aged; Child; Clinical Trials as Topic; Cytarabine; Herpes Zoster; Hodgkin Disease; Humans; Immunosuppressive Agents; Interferons; Lymphoma, Non-Hodgkin; Prednisone; Triamcinolone; Vidarabine | 1980 |
7 other study(ies) available for triamcinolone and cytarabine
Article | Year |
---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Low-dosage cytarabine therapy for herpes zoster with pneumonia.
Topics: Biopsy; Brachial Plexus; Cytarabine; Herpes Zoster; Humans; Infusions, Parenteral; Male; Middle Aged; Neuralgia; Pneumonia, Viral; Radiography; Skin; Staphylococcus; Triamcinolone | 1975 |
Recent therapeutic advances for common cutaneous problems.
Topics: Acne Vulgaris; Administration, Topical; Coloring Agents; Cytarabine; Dermatologic Agents; Ethyl Ethers; Female; Glutaral; Herpes Simplex; Herpes Zoster; Humans; Ichthyosis; Injections, Intradermal; Injections, Intravenous; Male; Phototherapy; Skin Diseases, Infectious; Stomatitis, Aphthous; Tetracycline; Triamcinolone; Triamcinolone Acetonide; Urea; Vitamin A; Warts | 1974 |
Pruritic papules after induction chemotherapy with daunorubicin and cytarabine.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Cytarabine; Daunorubicin; Exanthema; Female; Humans; Induction Chemotherapy; Leukemia, Myeloid, Acute; Pruritus; Triamcinolone | 2022 |